Latest podcasts


Time-limited venetoclax and ibrutinib for patients with R/R CLL and undetectable MRD

Prof. Carsten Niemann, Department of Clinical Medicine, University of Copenhagen, Denmark

Talha Munir about ibrutinib plus venetoclax vs chlorambucil plus obinutuzumab for CLL patients

Dr. Talha Munir, Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom
All podcasts